1. |
陈贵海, 张立强, 高雪梅, 等. 成人阻塞性睡眠呼吸暂停多学科诊疗指南. 中华医学杂志, 2018, 98(24): 1902-1914.
|
2. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版). 中华结核和呼吸杂志, 2021, 44(3): 170-205.
|
3. |
Cao Y, Xing ZZ, Long HY, et al. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respir Res, 2021, 22(1): 77.
|
4. |
Zhu J, Zhao ZL, Nie QR, et al. Effect of lung function on the apnea-hypopnea index in patients with overlap syndrome: a multicenter cross-sectional study. Sleep Breath, 2020, 24(3): 1059-1066.
|
5. |
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med, 2019, 7(8): 687-698.
|
6. |
Zhang P, Chen B, Lou HQ, et al. Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary dis ease in China. BMC Pulm Med, 2022, 22(1): 16.
|
7. |
Rafanan AL, Baquilod RA. Sleep-related breathing complaints in chronic obstructive pulmonary disease. Sleep Med Clin, 2022, 17(1): 99-109.
|
8. |
D'Cruz RF, Murphy PB, Kaltsakas G. Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classific ation, pathophysiology and clinical outcomes. J Thorac Dis, 2020, 12(Suppl 2): S202-S216.
|
9. |
Ioachimescu OC, Janocko NJ, Ciavatta MM, et al. Obstructive Lung Disease and Obstructive Sleep Apnea (OLDOSA) cohort study: 10-year assessment. J Clin Sleep Med, 2020, 16(2): 267-277.
|
10. |
Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail, 2021, 23(3): 352-380.
|
11. |
沈久成, 孙丽, 王婧, 等. 阻塞性睡眠呼吸暂停对慢性阻塞性肺疾病患者心肺功能的影响. 中华医学杂志, 2021, 101(22): 1665-1670.
|
12. |
Kendzerska T, Leung RS, Aaron SD, et al. Cardiovascular outcomes and all-cause mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome). Ann Am Thorac Soc, 2019, 16(1): 71-81.
|
13. |
Spicuzza L, Campisi R, Crimi C, et al. Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstruct ive pulmonary disease. Eur J Intern Med, 2019, 69: e15-e16.
|
14. |
McNicholas WT. Does associated chronic obstructive pulmonary disease increase morbidity and mortality in obstructive sleep apnea?. Ann Am Thorac Soc, 2019, 16(1): 50-53.
|
15. |
Adler D, Bailly S, Benmerad M, et al. Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome. PLoS ONE, 2020, 15(7): e0235331.
|
16. |
熊梦清, 蔡永芳, 胡克. 慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停交互作用的研究现状. 中国呼吸与危重监护杂志, 2018, 17(3): 309-312.
|
17. |
Wang YY, Li BH, Li P, et al. Severe obstructive sleep apnea in patients with chronic obstructive pulmonary disease is associated with an increased prevalence of mild cognitive impairment. Sleep Med, 2020, 75: 522-530.
|
18. |
Voulgaris A, Archontogeorgis K, Steiropoulos P, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, obstructive sleep apnoea syndrome and overlap syndrome. Curr Vasc Pharmacol, 2021, 19(3): 285-300.
|
19. |
Papachatzakis I, Velentza L, Zarogoulidis P, et al. Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea - overlap syndrome. Eur Rev Med Pharmacol Sci, 2018, 22(13): 4325-4331.
|
20. |
Lacedonia D, Carpagnano GE, Patricelli G, et al. Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome. Clin Respir J, 2018, 12(5): 1905-1911.
|
21. |
Rha MS, Kim CH, Yoon JH, et al. Association between the neutrophil-to-lymphocyte ratio and obstructive sleep apnea: a meta-analysis. Sci Rep, 2020, 10(1): 10862.
|
22. |
Li SQ, Sun XW, Zhang L, et al. Impact of insomnia and obstructive sleep apnea on the risk of acute exacerbation of chronic obstructi ve pulmonary disease. Sleep Med Rev, 2021, 58: 101444.
|
23. |
Du W, Liu J, Zhou J, et al. Obstructive sleep apnea, COPD, the overlap syndrome, and mortality: results from the 2005-2008 Nation al Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis, 2018, 13: 665-674.
|
24. |
Gómez-Rosero JA, Cáceres-Galvis C, Ascuntar J, et al. Biomarkers as a prognostic factor in COPD exacerbation: a cohort study. COPD, 2021, 18(3): 325-332.
|
25. |
Acanfora D, Scicchitano P, Carone M, et al. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med, 2018, 18(1): 116.
|
26. |
Fitzgibbons CM, Goldstein RL, Gottlieb DJ, et al. Physical activity in overlap syndrome of COPD and obstructive sleep apnea: relationship with markers of systemic inflammation. J Clin Sleep Med, 2019, 15(7): 973-978.
|
27. |
Zhou W, Li CL, Cao J, et al. Metabolic syndrome prevalence in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease: relationship with systemic inflammation. Clin Respir J, 2020, 14(12): 1159-1165.
|
28. |
Vanfleteren LE, Beghe B, Andersson A, et al. Multimorbidity in COPD, does sleep matter?. Eur J Intern Med, 2020, 73: 7-15.
|
29. |
Orr JE, Schmickl CN, Edwards BA, et al. Pathogenesis of obstructive sleep apnea in individuals with the COPD + OSA overlap syndrome versus OSA alone. Physiol Rep, 2020, 8(3): e14371.
|